Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (ALGS)

Historical Holders from Q3 2024 to Q2 2025

Symbol
ALGS on Nasdaq
CUSIP
01626L204
Type / Class
Equity / Voting Common Stock, par value $0.0001 per share
Shares outstanding
5.29M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
2.71M
Holdings value
$19.5M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
37
Number of buys
17
Number of sells
-15
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (ALGS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Alyeska Investment Group, L.P. 9.99% $2.16M 530K Alyeska Investment Group, L.P. Mar 31, 2025
Woodline Partners LP 9.8% +92% $3.86M $1.51M 518K +64.3% Woodline Partners LP Jun 30, 2025
Sio Capital Management, LLC 5.49% $2.65M 356K Sio Capital Management, LLC Jun 30, 2025
EcoR1 Capital, LLC 3.9% $859K 211K EcoR1 Capital, LLC Mar 31, 2025
Adage Capital Management, L.P. 3.9% -60.9% $1.51M -$829K 210K -35.4% Adage Capital Management, L.P. Jun 30, 2025
ARMISTICE CAPITAL, LLC 4.99% $769K 188K Armistice Capital, LLC Dec 31, 2024
BLATT LAWRENCE 3.2% $716K 176K Lawrence M. Blatt, Ph.D. Mar 10, 2025

Institutional Holders of Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (ALGS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 2.71M $19.5M -$4.85M $7.21 37
2025 Q1 3.3M $27.1M +$7.68M $8.25 35
2024 Q4 1.62M $64.5M +$11.8M $39.84 32
2024 Q3 1.69M $14.7M +$14.6M $8.66 27